Jochen Reiser MD Ph.D.

PubMed

• Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders.
  Mehmet M Altintas, Shivangi Agarwal, Yashwanth Sudhini, Ke Zhu, Changli Wei
  Annual Review of Pathology. 2025-01-01
• Treatment of Podocytopathies: Risky Business and Our Personal Journey.
  Sanja Sever, Jochen Reiser
  Journal of the American Society of Nephrology. 2024-11-01
• 1 citations
  Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study.
  Christina G Hutten, Kishan Padalia, Alexi Vasbinder, Yiyuan Huang, Anis Ismail
  The Journal of Clinical Endocrinology and Metabolism. 2024-10-15

Journal Articles

• Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19  
  Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
• Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US  
  Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Alexandre M Shehata, Nitender G..., JAMA Internal Medicine
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) Is Predictive of Non-AIDS Events During Antiretroviral Therapy-Mediated Viral Suppression  
  Michael M Lederman, Jochen Reiser, Clinical Infectious Diseases